Available data also suggested that increased SphK1 markedly contributed to deep invasion, lymph node metastasis, and poor five-year overall survival, highlighting the exciting potential of SphK1 as a prognostic marker [154,155]. The gene discussed is SPHK1; the disease is metastatic malignant neoplasm in the lymph nodes.